Cytocompatibility of the ready-to-use bioceramic putty repair cement iRoot BP Plus with primary human osteoblasts

International Endodontic Journal

Volumn 45, Issue 6, 2012, Pages 508-513

  De Deus, G ^a   Canabarro, A ^b   Alves, G G ^c,d   Marins, J R ^e   Linhares, A B R ^d   Granjeiro, J M ^c,d,f  

^a Grande Rio University UNIGRANRIO   (Brazil)

^b VEIGA DE ALMEIDA UNIVERSITY   (Brazil)

^c FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^d HOSPITAL UNIVERSITÁRIO ANTÔNIO PEDRO   (Brazil)

^e STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^f INSTITUTO NACIONAL DE METROLOGIA   (Brazil)

Author keywords

Bioceramic; Biocompatibility; Mineral trioxide aggregate; Osteoblasts; Ready to use repair material

Indexed keywords

ALUMINUM DERIVATIVE; BIOMATERIAL; CALCIUM DERIVATIVE; CALCIUM SILICATE; MINERAL TRIOXIDE AGGREGATE; OXIDE; SILICATE; SILICATE CEMENT; ZINC OXIDE EUGENOL;

ARTICLE; CELL COUNT; CELL MEMBRANE; CELL SHAPE; CELL SURVIVAL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CULTURE MEDIUM; CULTURE TECHNIQUE; DRUG COMBINATION; DRUG EFFECT; ENDODONTICS; HUMAN; METHODOLOGY; MITOCHONDRION; OSTEOBLAST; RANDOMIZED CONTROLLED TRIAL; TIME; TISSUE CULTURE TECHNIQUE;

ALUMINUM COMPOUNDS; BIOCOMPATIBLE MATERIALS; CALCIUM COMPOUNDS; CELL COUNT; CELL CULTURE TECHNIQUES; CELL MEMBRANE; CELL SHAPE; CELL SURVIVAL; CULTURE MEDIA, CONDITIONED; DRUG COMBINATIONS; HUMANS; MITOCHONDRIA; OSTEOBLASTS; OXIDES; RETROGRADE OBTURATION; ROOT CANAL PREPARATION; SILICATE CEMENT; SILICATES; TIME FACTORS; TISSUE CULTURE TECHNIQUES; ZINC OXIDE-EUGENOL CEMENT;

EID: 84860700829     PISSN: 01432885     EISSN: 13652591     Source Type: Journal    
DOI: 10.1111/j.1365-2591.2011.02003.x     Document Type: Article

References (32)

1. Abdullah D, Ford TR, Papaioannou S, Nicholson J, McDonald F (2002) An evaluation of accelerated Portland cement as a restorative material. Biomaterials 23, 4001-10.
2. Asgary S, Parirokh M, Eghbal MJ, Brink F (2005) Chemical differences between white and gray mineral trioxide aggregate. Journal of Endodontics 31, 101-3.
3. Bortoluzzi EA, Araujo GS, Guerreiro Tanomaru JM, Tanomaru-Filho M (2007) Marginal gingiva discoloration by gray MTA: a case report. Journal of Endodontics 33, 325-7.
4. Bortoluzzi EA, Broon NJ, Bramante CM et al. (2008) Mineral trioxide aggregate with or without calcium chloride in pulpotomy. Journal of Endodontics 34, 172-5.
5. Camilleri J, Pitt Ford TR (2006) Mineral trioxide aggregate: a review of the constituents and biological properties of the material. International Endodontic Journal 39, 747-54.
6. Chng HK, Islam I, Yap AU, Tong YW, Koh ET (2005) Properties of a new root-end filling material. Journal of Endodontics 31, 665-8.
7. De-Deus G, Ximenes R, Gurgel-Filho ED, Plotkowski MC, Coutinho-Filho T (2005) Cytotoxicity of MTA and Portland cement on human ECV 304 endothelial cells. International Endodontic Journal 38, 604-9.
8. De-Deus G, Petruccelli V, Gurgel-Filho E, Coutinho-Filho T (2006) MTA versus Portland cement as repair material for furcal perforations: a laboratory study using a polymicrobial leakage model. International Endodontic Journal 39, 293-8.
9. De-Deus G, Canabarro A, Alves G, Linhares A, Senne MI, Granjeiro JM (2009) Optimal cytocompatibility of a bioceramic nanoparticulate cement in primary human mesenchymal cells. Journal of Endodontics 35, 1387-90.
10. DeWald JP (1997) The use of extracted teeth for in vitro bonding studies: a review of infection control considerations. Dental Materials 13, 74-81.
11. Gorduysus M, Avcu N, Gorduysus O et al. (2007) Cytotoxic effects of four different endodontic materials in human periodontal ligament fibroblasts. Journal of Endodontics 33, 1450-4.
12. Holland R, de Souza V, Murata SS et al. (2001a) Healing process of dog dental pulp after pulpotomy and pulp covering with mineral trioxide aggregate or Portland cement. Brazilian Dental Journal 12, 109-13.
13. Holland R, de Souza V, Nery MJ et al. (2001b) Reaction of rat connective tissue to implanted dentin tube filled with mineral trioxide aggregate, Portland cement or calcium hydroxide. Brazilian Dental Journal 12, 3-8.
14. International Standards Organization (ISO) (2008) ISO 7405:2008. Dentistry - Evaluation of biocompatibility of medical devices used in dentistry. International Standards Organization, Geneva, Switzerland.
15. International Standards Organization (ISO) (2009) ISO 10993-5:2009. Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity. International Standards Organization, Geneva, Switzerland.
16. Islam I, Chng HK, Yap AU (2006) Comparison of the physical and mechanical properties of MTA and portland cement. Journal of Endodontics 32, 193-7.
17. Keiser K, Johnson CC, Tipton DA (2000) Cytotoxicity of mineral trioxide aggregate using human periodontal ligament fibroblasts. Journal of Endodontics 26, 288-91.
18. Komabayashi T, Spångberg LS (2008) Particle size and shape analysis of MTA finer fractions using Portland cement. Journal of Endodontics 34, 709-11.
19. Kueng W, Silber E, Eppenberger U (1989) Quantification of cells cultured on 96-well plates. Analytical Biochemistry 182, 16-9.
20. Mangin C, Yesilsoy C, Nissan R, Stevens R (2003) The comparative sealing ability of hydroxyapatite cement, mineral trioxide aggregate, and super ethoxybenzoic acid as root-end filling materials. Journal of Endodontics 29, 261-4.
21. Min KS, Park HJ, Lee SK et al. (2008) Effect of mineral trioxide aggregate on dentin bridge formation and expression of dentin sialoprotein and heme oxygenase-1 in human dental pulp. Journal of Endodontics 34, 666-70.
22. Mitchell PJ, Pitt Ford TR, Torabinejad M, McDonald F (1999) Osteoblast biocompatibility of mineral trioxide aggregate. Biomaterials 20, 167-73.
23. Pace R, Giuliani V, Pagavino G (2008) Mineral trioxide aggregate as repair material for furcal perforation: case series. Journal of Endodontics 34, 1130-33.
24. Parirokh M, Torabinejad M (2010a) Mineral trioxide aggregate: a comprehensive literature review - Part I: chemical, physical, and antibacterial properties. Journal of Endodontics 36, 16-27.
25. Parirokh M, Torabinejad M (2010b) Mineral trioxide aggregate: a comprehensive literature review - Part III: Clinical applications, drawbacks, and mechanism of action. Journal of Endodontics 36, 400-13.
26. Pelliccioni GA, Vellani CP, Gatto MR, Gandolfi MG, Marchetti C, Prati C (2007) Proroot mineral trioxide aggregate cement used as a retrograde filling without addition of water: an in vitro evaluation of its microleakage. Journal of Endodontics 33, 1082-5.
27. Rosa AL, Beloti MM (2003) Effect of cpTi surface roughness on human bone marrow cell attachment, proliferation, and differentiation. Brazilian Dental Journal 14, 16-21.
28. Sarris S, Tahmassebi JF, Duggal MS, Cross IA (2008) A clinical evaluation of mineral trioxide aggregate for root-end closure of non-vital immature permanent incisors in children-a pilot study. Dental Traumatology 24, 79-85.
29. Scudiero DA, Shoemaker RH, Paull KD et al. (1988) Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Research 48, 4827-33.
30. Torabinejad M, Chivian N (1999) Clinical applications of mineral trioxide aggregate. Journal of Endodontics 25, 197-205.
31. Winckler J (1974) [Vital staining of lysosomes and other cell organelles of the rat with neutral red (author's transl)]. Progress in Histochemistry and Cytochemistry 6, 1-91.
32. Zhu Q, Haglund R, Safavi KE, Spangberg LS (2000) Adhesion of human osteoblasts on root-end filling materials. Journal of Endodontics 26, 404-6.